Ironwood Pharmaceuticals (IRWD) Net Equity Issued and Repurchased (2012 - 2014)

Ironwood Pharmaceuticals (IRWD) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $28000.0 in Q2 2014.

• For the quarter ending Q2 2014, Net Equity Issued and Repurchased fell 99.98% year-over-year to $28000.0; the trailing twelve-month figure through Dec 2014 stood at $190.4 million (up 38.19% YoY), and the FY2014 full-year result was $190.4 million, up 38.23% from the prior year.
• Net Equity Issued and Repurchased declined to $28000.0 in Q2 2014, from $190.4 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $190.4 million in Q1 2014 to a low of $28000.0 in Q2 2014.
• A 3-year average of $103.4 million and a median of $111.5 million in 2012 frame the typical range for Net Equity Issued and Repurchased.
• Peak annual rise in Net Equity Issued and Repurchased reached 99.98% in 2014, while the deepest fall reached 99.98% in 2014.
• Tracing IRWD's Net Equity Issued and Repurchased over 3 years: stood at $85.2 million in 2012, then surged by 61.68% to $137.8 million in 2013, then plunged by 99.98% to $28000.0 in 2014.
• Business Quant data shows IRWD's Net Equity Issued and Repurchased at $28000.0 in Q2 2014, $190.4 million in Q1 2014, and $137.8 million in Q2 2013.